Showing results (11-20 of 16) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Advanced Biosystems|April 16, 2020
Engineered Ovarian Cancer Cell Lines for Validation of CAR T Cell FunctionClaire E Repellin, Priya Ganesan, Javier F Alcudia, et al.Molecular Biology of the Cell|October 1, 2010
Type II transforming growth factor-beta receptor recycling is dependent upon the clathrin adaptor protein Dab2Sumedha G Penheiter, Raman Deep Singh, Claire E Repellin, et al.Cancer Research|November 23, 2012
Resistance to irreversible EGF receptor tyrosine kinase inhibitors through a multistep mechanism involving the IGF1R pathwayAlexis B Cortot, Claire E Repellin, Takeshi Shimamura, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 6, 2013
Profibrotic TGFβ responses require the cooperative action of PDGF and ErbB receptor tyrosine kinasesMahefatiana Andrianifahanana, Mark C Wilkes, Shiv K Gupta, et al.Cancer Research|April 2, 2017
Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 InhibitorsTakayuki Kosaka, Junko Tanizaki, Raymond M Paranal, et al.Cancer Research|November 6, 2025
Enozertinib is a Selective, Brain-penetrant EGFR inhibitor for Treating Non-small Cell Lung Cancers with EGFR Exon 20 and Atypical MutationsMelissa R Junttila, Claire E Repellin, Sumeet Salaniwal, et al.Pageof 2